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LETTER TO JCP
Clinical phenotype of haemoglobin Q-H disease
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J Clin Pathol 2004;57:81–82
Seven patients of Chinese origin who had haemoglobin (Hb)
Q-H disease were studied. They were found to have a similar
clinical phenotype to that of patients with deletional Hb H
disease, who have a near identical genotypic configuration.
The complete absence of Hb A in Hb Q-H disease and the
similar clinical phenotype to deletional Hb H disease lends
support to the observation that Hb Q-Thailand shares similar
functional properties with Hb A.
T
he haemoglobin (Hb) Q-Thailand mutation is an
a globin chain variant that results from a point mutation
(GAC R CAC; Asp R His) in codon 74 of the a1 globin
gene on chromosome 16p with a leftward single a globin
gene deletion (2a4.2).1 2 Individuals who are heterozygous for
Hb Q-Thailand usually show slight red cell microcytosis
because the mutation is invariably linked to (2a4.2), and this
mutation has been reported in subjects of Chinese, Thai, and
Japanese origin.3 In contrast, Hb Q-H disease, caused by the
co-inheritance of Hb Q-Thailand and a0 thalassaemia, has
only been reported in Chinese families. The genotype of Hb
Q-H disease is – –/2aQ. Molecular analysis of Hb Q-H disease
commonly shows that the (– –SEA) a-thalassaemia deletion
(SEA deletion) is the a0 thalassaemia determinant.4 Hb Q-H
disease manifests as chronic anaemia associated with
jaundice and hepatosplenomegaly.5 Affected individuals
show a thalassaemic blood picture resembling Hb H disease,
but Hb analysis shows absence of Hb A, with Hb Q-Thailand
being the predominant fraction.2 We report the clinical
phenotype of seven unrelated patients with Hb Q-H disease,
the largest series to date of this relatively uncommon
thalassaemic disorder in the Chinese, diagnosed since 1995
at our laboratory, which receives referrals of Hb disorders
from all over the territory.
‘‘Haemoglobin Q-H disease manifests as chronic
anaemia associated with jaundice and
hepatosplenomegaly’’
HAEMATOLOGICAL AND CLINICAL FINDINGS
Table 1 details the clinical and haematological data. All of the
study subjects are Hong Kong Chinese, with patient number
7 being of Chinese descent from Thailand. Diagnosis was
made on Hb pattern studies in all cases. Archival blood
samples were of sufficient quantity for genotype determina-
tion in four individuals (patients 3, 4, 5, and 7). Genotyping
revealed the Hb Q-Thailand mutation, as confirmed by direct
nucleotide sequencing of the a1 globin gene, together with
4.2 kb single a globin gene deletion and SEA deletion, as
detected by multiplex polymerase chain reaction. Hb A was
absent and Hb Q-Thailand accounted for 93.9–97.9% of the
total Hb. There was a high proportion of Hb H inclusion
bodies, which were detected in 70–90% of red blood cells in
these patients on supravital staining.
These seven patients were anaemic with steady state Hb
concentrations ranging from 79 g/litre to 109 g/litre (mean,
97 g/litre). None of them required regular transfusions,
although three of the seven had a history of infrequent blood
transfusions. The other four had never been transfused. Four
of the patients had splenomegaly, and splenectomy was
performed in two as a result of hypersplenism. Two patients
showed hepatomegaly. The six patients with iron studies
available showed raised ferritin values, but none was put on
iron chelation treatment.
DISCUSSION
Patients with Hb Q-H disease can be categorised under
deletional Hb H disease, because genotypically they show
deletion of three a globin genes.6 Therefore, we compared the
clinical features of Hb Q-H disease with those of Hb H disease
caused by the (– –/2a4.2) configuration in our archive,
because their genetic configurations are almost identical.
There appears to be no significant difference between the two
groups with respect to clinical phenotype (table 1). Our
results are entirely in accordance with the observation that
Hb Q-Thailand shows normal oxygen affinity, Bohr effect,
and cooperativity.3 Thus, patients with Hb Q-H disease have
similar clinical features to patients with deletional Hb H
disease, even though Hb A is absent in the former condition.
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Take home messages
N Seven Chinese patients with haemoglobin (Hb) Q-H
disease were found to have a similar clinical phenotype
to that of patients with deletional Hb H disease, which
has a near identical genotypic configuration
N The complete absence of Hb A in Hb Q-H disease and
the similar clinical phenotype to deletional Hb H
disease lends support to the observation that Hb Q-
Thailand shares similar functional properties with Hb A
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Table 1 Haematological and clinical profiles of patients with Hb Q-H disease
Patient Sex
Age
(years) L S
History of
transfusion
Hb
(g/l)
MCV
(fl)
MCH
(pg)
Hb H
(%)
Hb A
(%)
Hb A2
(%)
Hb F
(%)
Hb Q-
Thailand
(%)
Retic
(%)
Bilirubin
(mmol/l)
Iron
(mmol/l)
Ferritin
(pmol/l)
Transferrin
saturation
(%)
1 M 58 N N N 96 83.4 20.0 70 0 0.3 ,0.3 97.9 – – 39 5200 –
2 M 17 N N N 105 60.5 18.5 80 0 3.4 ,0.3 93.9 – – – – –
3 M 28 Y Y N 100 63.6 18.8 90 0 2.7 ,0.3 95.6 9.2 90 32 1430 77
4 M 23 N Y* Y 105 59.7 18.4 89 0 2.4 ,0.3 95.8 4.7 35 20 965 16
5 M 38 N N N 10.9 66.6 18.1 90 0 3.0 0.5 94.2 3.7 30 21 1530 38
6 F 68 N Y* Y 79 70.2 18.9 70 0 2.1 ,0.3 93.9 6.5 – 25 467 –
7` F 49 Y Y Y 84 77.2 21.7 85 0 1.2 ,0.3 96.9 5.0 26 – 1907 –
HbH
disease
– –SEA/
2a4.2
(n = 12)1
35 1
case
4
cases
3 cases, all
transfusion
independent
94 63.9 17.0 65 NA NA NA NA 5.0 29.1 20 1108 41
*Splenectomy performed; gallstones present; `hepatitis C carrier, liver biopsy showed chronic hepatitis and grade 2 iron overload (modified Scheuer grading);
1mean values quoted for age and laboratory parameters in these 12 patients with deletional HbH disease as a result of – –SEA/2a4.2 configuration; splenectomy
performed in one patient.
Reference ranges: Hb, 130–180 g/l (men), 115–165 g/l (women); MCV, 80–96 fl; MCH, 27–32 pg; HbA2, 2.3–3%; HbF,0.9%; reticulocytes, 0.2–2%;
bilirubin, 7–19 mmol/l; iron, 9–33 mmol/l (men), 5–28 mmol/l (women); ferritin, 115–884 pmol/l (men), 15–331 pmol/l (women); transferrin saturation, 15–
45%.
Hb, haemoglobin; Hb H, percentage of red cells with HbH inclusions; L, hepatomegaly; MCH, mean cell haemoglobin; MCV, mean cell volume; N, absent; NA,
not applicable; Retic, reticulocytes; S, splenomegaly; Y, present; –, data not available.
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